PEDBASE.org - The Pediatric Database -
Detailed information of MENKES (KINKY HAIR) DISEASE
MENKES (KINKY HAIR) DISEASE
DEFINITION:
A progressive neurodegenerative disorder characterized by
degeneration of the CNS grey matter with distinctive facies and hair
and progressive neurological deterioration.
EPIDEMIOLOGY:
- incidence: 1/35-50,000 male live births
- age of onset:
- risk factors:
- familial - X-linked recessive
- chrom. #: Xq13.3
- gene: Copper-binding P-type ATPase
PATHOGENESIS:
- there are 3 inherited disorders known to be caused by
genetic defects in copper metabolism:
- Wilson Disease
- Menkes Disease
- Occipital Horn Syndrome
- isolation of the Menkes disease gene (Cu-binding P-type
ATPase) was first reported in 1993 by three groups (Vulpe et.
al, Chelly et al., Mercier et al., Nature Genetics 3:7-25, 1993)
and is a member of a cation-transporting P-type ATPase subfamily
- expression of the Cu-binding P-type ATPase occurs in all
tissues except the liver and thus on biopsy there is increased
copper deposition in intestinal and kidney samples but decreased
copper deposition in liver samples taken from patients with
Menkes Disease (Chelly and Monaco, Nature Genetics 5:317-318,
1993)
- the function of cuproenzymes is dependent on copper:
- ascorbate oxidase, cytochrome c oxidase, lysyl oxidase,
monamide oxidase
2. Others
- dopamine-beta-hydroxylase, superoxide dismutase,
tyrosinase
2. Genetic Defect
- genetic defect -> decreased copper transport across cellular
compartments (particularly in the gut) -> decreased availability
of copper for cuproenzymes -> dysfunction of numerous
copper-dependent enzyme systems:
- ascorbate oxidase - skeletal deformities
- cytochrome c oxidase - hypothermia
- lysyl oxidase - intimal cleavage
- monamide oxidase - kinky hair
- tyrosinase - depigmentation of hair, skin pallor
- because the defective gene is expressed in all other tissues
except the liver, there is an intracellular non-toxic
accumulation of copper throughout the body except in the liver
- the main difference in pathogenesis between Menkes Disease
and Wilson Disease is that in the former there is not a toxic
accumulation of copper throughout the body but dysfunction of
numerous copper-dependent enzyme systems
PATHOLOGY:
- extensive focal degeneration of grey matter with axonal
degeneration in the white matter
- loss of internal granule cell layer and necrosis of Purkinje
cells within the cerebellum
- tortuous cerebral vessels
CLINICAL FEATURES:
1. Neurological Manifestations
1. Initial
- presents in the neonatal period with:
- generalized seizures
- myoclonic (occasionally tonic-clonic)
- most common initial symptom
- peak incidence at 3 months of age
- hypotonia with prolonged head lag
- hypothermia
2. Later
- motor developmental delay
- severe mental retardation
- progressive neurologic deterioration with death usually by
2 years of age (although some as old as 13 years)
2. Other Manifestations
1. Secondary Hair
- kinky, colourless, friable
- includes scalp, eyebrow, and eyelash hair
2. Distinctive Facies
- chubby, rosy cheeks
- depressed nasal bridge
- expressionless face
3. Ocular
- pale optic discs
- optic atrophy -> blindness
4. Others
- arterial rupture/thrombosis
- cutis laxa
- feeding difficulties with failure to thrive
- hematuria
- hypothermia
INVESTIGATIONS:
1. Serum
- low copper and ceruloplasmin levels (initially low in the
neo-natal period so may need serial assessment)
2. Hair
- microscopic examination of hair shaft
- monilethrix (periodic narrowing)
- pili torti (twisted)
- trichorrhexis nodosa (fractures)
3. Imaging Studies
1. MRI/CT
- cortical areas of encephalomalacia (low density areas)
- progressive degeneration of grey matter
- cerebral atrophy
- subdural hematomas
2. Cerebral Angiogram
3. Skeletal X-Rays
- flaring of anterior ribs
- long bones
- metaphyseal spurring
- diphyseal periosteal reaction
4. Renal Ultrasound
- bladder diverticulate
- hydronephrosis
- hydroureter
4. Electrodiagnostic
- EEG - hypsarrhythmia after 5 months of age
- Evoked Potentials - low amplitude or absent
5. Diagnostic
- reduced activity of cuproenzymes particularly cytochrome c
oxidase and superoxide dismutase
- intrauterine - increased copper content of fibroblasts or
chorionic villi
- in vitro - increased copper accumulation with decreased
copper release
MANAGEMENT:
1. Copper
1. Parenteral
- cupric acetate 550-800 ug/kg/day till copper and
ceruloplasmin levels are normal then 190-220 ug/kg IV twice
per week
- normalizes serum copper and ceruloplasmin levels but not
CNS copper levels and while improving seizure control will not
interrupt the progression of neurologic manifestations
2. Intramuscular
- copper histidinate 250-600 ug/d
- may be able to cross the blood-brain barrier and thus
interrupt the progression of neurological manifestations
|
Pediatric Database - MENKES (KINKY HAIR) DISEASE
Pediatric Organization - Pedbase [at] Gmail.com